PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
10-Dec-2025 Model N Launches Data nSights: Real-Time Analytics to Drive Action and Optimize Net Revenue Model N
10-Dec-2025 Provepharm expands presence in medical dyes and enters fluorescence era Andrew Lloyd Associates
09-Dec-2025 Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology Oncoinvent
09-Dec-2025 Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS) Newron
09-Dec-2025 PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech
09-Dec-2025 Poolbeg Pharma plc - POLB 001 trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg Pharma
09-Dec-2025 SeaBeLife enters into joint development agreement with Unither Pharmaceuticals to formulate and produce ophthalmic drug candidate SeaBeLife
09-Dec-2025 Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer Pan Cancer T
09-Dec-2025 Senzime secures major TetraGraph order from leading UK NHS hospital system Senzime
09-Dec-2025 Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory Board with a focus on its lead indication Alport Syndrome Fibrocor Therapeutics
09-Dec-2025 Chiesi Marks Key Net Zero Milestone with its First Carbon Minimal pMDI Product Submission to the MHRA for Clenil® Modulite® (beclometasone) Chiesi
08-Dec-2025 Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer Pan Cancer T
08-Dec-2025 SeaBeLife enters into joint development agreement with Unither Pharmaceuticals to formulate and produce ophthalmic drug candidate Andrew Lloyd Associates
05-Dec-2025 7 Million Psoriasis Patients See New Hope: China Launches Its First IL-23p19 Inhibitor Picankibart dengyuemed
04-Dec-2025 IDA Ireland publishes whitepaper on the future of biopharmaceutical manufacturing in Ireland IDA Ireland
04-Dec-2025 Model N Launches Data nSights: Real-Time Analytics to Drive Action and Optimize Net Revenue Model N
04-Dec-2025 UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting UCB
04-Dec-2025 The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of pegcetacoplan for C3G and Primary IC-MPGN Sobi
04-Dec-2025 Clinigen targets validated by SBTi, setting verified path to Net-Zero Clinigen
04-Dec-2025 Vortex Launches Clinical Study Using Liquid Biopsy Technology to Advance Cancer Monitoring Vortex